Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.49 |
| ▸ | ALOX12 | P18054 | 5/20 | 0.49 |
| ▸ | GLA | P06280 | 2/20 | 0.49 |
| ▸ | NPC1 | O15118 | 3/20 | 0.46 |
| ▸ | RAB9A | P51151 | 3/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.45 |
| ▸ | MITF | O75030 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.42 |
| ▸ | MEN1 | O00255 | 3/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5530336 | 0.84 | ALDH1A1 (0.48) | ALDH1A1ALOX12GLANPC1RAB9A | |
| SCHEMBL2584410 | 0.83 | ALDH1A1 (0.65) | ALDH1A1ALOX12GLANPC1RAB9A | |
| SCHEMBL5126108 | 0.82 | NPC1 (0.54) | ALDH1A1ALOX12GLANPC1RAB9A | |
| SCHEMBL5123025 | 0.80 | NPC1 (0.60) | ALDH1A1ALOX12GLANPC1RAB9A | |
| SCHEMBL5392388 | 0.78 | ALDH1A1 (0.51) | ALDH1A1ALOX12GLANPC1RAB9A | |
| SCHEMBL5121035 | 0.77 | ALDH1A1 (0.48) | ALDH1A1ALOX12GLANPC1RAB9A | |
| SCHEMBL7474517 | 0.77 | RAB9A (0.65) | ALDH1A1ALOX12GLANPC1RAB9A | |
| SCHEMBL13565116 | 0.77 | NPY5R (0.38) | ALDH1A1SMN1; SMN2CYP3A4 | |
| SCHEMBL7475623 | 0.77 | NPC1 (0.66) | ALDH1A1ALOX12GLANPC1RAB9A | |
| SCHEMBL4290054 | 0.77 | NPC1 (0.66) | ALDH1A1ALOX12GLANPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070213376-A1 | Halogenated sulfonamide derivatives | H. LUNDBECK A/S (DK) | 2007-09-13 | — | — | US | disclosed |
| US-20060293341-A1 | Alkyl sulfonamide derivatives | H. LUNDBECK A/S (DK) | 2006-12-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070213376-A1 | Halogenated sulfonamide derivatives | NPY5R, NPY2R, SSTR5 | ALDH1A1 1835/4885ALOX12 2665/4885GLA 3082/4885 |
| US-20060293341-A1 | Alkyl sulfonamide derivatives | NPY5R, NPY1R, NPY4R | ALDH1A1 1893/4885ALOX12 1838/4885GLA 2479/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.